This snapshot of information is intended to provide resources to individuals, parents, professionals, and providers on fentanyl use among Latinos in the United States.
HOJA INFORMATIVA SOBRE EL FENTANILO PARA LOS PROVEEDORES
Esta síntesis de información tiene por objeto proporcionar recursos a las personas, los padres, los profesionales y los proveedores sobre el consumo de fentanilo entre los Latinos en los Estados Unidos.
DESCRIPTION:
As the illicit opioid supply includes more and more fentanyl, there have been increasing concerns about increasing rates of buprenorphine initiation precipitating opioid withdrawal. This session will describe why we believe this is happening, how common it is, and buprenorphine initiation strategies to support patients in avoiding precipitated withdrawal.
LEARNING OBJECTIVES:
Describe the challenges of buprenorphine initiation in the fentanyl era.
Name three potential approaches to buprenorphine initiation.
Counsel on reducing fentanyl-related harms.
TRAINER:
Elizabeth Salisbury-Afshar, MD, MPH is an Associate Professor in the Departments of Family Medicine and Community Health and Population Health Sciences at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. She is the Program Director of the Preventive Medicine Residency and core Faculty for the Addiction Medicine Fellowship. Dr. Salisbury-Afshar is board certified in family medicine, preventive medicine/public health and addiction medicine and her expertise lies at the intersection of these fields. Her work has focused on expanding access to evidence-based substance use disorder treatment and harm reduction services. Past public health roles include serving as Medical Director of Behavioral Health Systems Baltimore, Medical Director at Heartland Alliance Health (a healthcare for the homeless provider in Chicago), and Medical Director of Behavioral Health at the Chicago Department of Public Health. Dr. Salisbury-Afshar received her Medical Degree from Rush University Medical College and her Master’s in Public Health from John Hopkins Bloomberg School of Public Health.
The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
Through the "One Pill Can Kill" campaign, the DEA is bringing awareness to the dangers of fentanyl, the threat of fake pills, and resources to keep people safe. The overarching goal was to provide participants with information about the "One Pill Can Kill" campaign and review a best practice communication strategy so participants felt confident in both their knowledge of the "One Pill Can Kill" campaign and in their ability to communicate it with others.
Learning Objectives
Gain knowledge on the dangers of fentanyl
Describe 3 key messages of the "One Pill Can Kill" awareness campaign
Be familiar with resources to support the "One Pill Can Kill" campaign
Review a best-practice communication strategy for sharing information
Speakers
Sean T. Fearns serves as the Chief of Community Outreach and Prevention Support for DEA since 2015. In this capacity, Sean is responsible for guiding a diverse and creative staff to develop and implement strategic national partnerships with other organizations which help educate the public on the current drug threats facing the country, support the DEA field divisions, implement DEA’s Operation Engage, communicate key administration drug prevention messages, and help reduce the demand for those drugs.
Alex Waitt, MS, MSEd, LPC, is a licensed professional counselor and the Co-Project Director for the Central East ATTC where he is responsible for the programmatic and administrative coordination of all training and technical assistance for the CE ATTC Region. He is the spokesperson and liaison to stakeholders and supports the development of other training and workforce initiatives.
RESOURCES
One Pill Can Kill DEA Campaign
Webinar slides
This webinar was provided by the Central East ATTC.
The Central East ATTC is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and managed by the Danya Institute.
Recording of TOR Webinar: Fentanyl and Harm Reduction. During this webinar, we will discuss fentanyl, including an overview of the pharmacology of fentanyl and fentanyl analogs, what we know about where fentanyl is being supplied from, and also how to implement fentanyl testing strips as a harm reduction intervention. This event took place on January 26th, 2022.
The video focuses on the fentanyl overdose death of a young man from Grand Forks, ND and includes an interview with Mountain Plains ATTC Co-Director Thomasine Heitkamp. Documentary produced by Voice of America, a U.S. government-funded international news source that serves as the U.S. Federal Government’s official institution for external broadcasting. Video is being distributed throughout the US (in English) and China (in Mandarin). https://www.voachinese.com/a/opioid-20180227/4273229.html
Sponsored by: California Department of Health Care Services (CA DHCS), Opioid and Stimulant Implementation Support-Training and Technical Assistance (OASIS-TTA)-MAT Expansion Project, UCLA Integrated Substance Abuse Programs (UCLA ISAP), Pacific Southwest Addiction Technology Transfer Center (PSATTC), HHS Region 9, & Opioid Response Network STR-TA
Course Description
This session will address “The Fourth Wave” of the opioid epidemic, including recent data on rising mortality due to fentanyl alone and in combination with methamphetamine. The rise of polysubstance use, including the use of the so called “goofball,” has implications for morbidity and mortality and raises the complexity of treatment. Treatment options, including use of medications, will be discussed. The session will also cover harm reduction strategies including naloxone, drug surveillance, and drug checking. This session will also include training on how to use fentanyl test strips, as part of a comprehensive public health and harm reduction strategy. Fentanyl test strips are a practical and effective tool for people who use drugs as means to encourage overdose risk education and reduce risk of death. Training will include discussion on distribution, limitations, sourcing, messaging amongst other considerations in the application and administration of use.
Launch Date: November 12, 2021
At the conclusion of the training, participants will be able to:
1. Recall the history, epidemiology and use patterns of two (2) drug classes, including synthetic opioids and stimulants.
2. Explain two (2) poly-drug use patterns involving synthetic opioids and methamphetamines and develop treatment strategies.
3. Propose three (3) harm reduction measures to prevent overdose deaths due to synthetic opioids.
4. Identify two (2) steps required when testing drug supply using Fentanyl Test Strips.
CME Statements:
The training course meets the qualifications for the provision of two (2.0) continuing medical education credits/contact hours (CMEs/CEHs).
Continuing Education:
The training course meets the qualifications for the provision of two (2.0) continuing education credits/contact hours (CEs/CEHs).
Estimated time to complete the course:
This course should take approximately 2 hours to complete.
Cost: Free
Disclosure statements:
Dan Ciccarone, MD, MPH – University of California, San Francisco
DISCLOSURES: Dr. Ciccarone is on the Scientific Advisory Board of Celero Systems and an expert witness in federal opioid litigation for Motley Rice LLC. All of the relevant financial relationships listed have been mitigated.
Amanda Cowan, MS – CLARE|MATRIX
DISCLOSURES: Reported no relevant financial relationships with commercial entities.
Trainers:
Dan Ciccarone, MD, MPH – University of California, San Francisco
Amanda Cowan, MS – CLARE|MATRIX
This webinar focuses on increasing knowledge among providers in the assessment and treatment of wounds as related to intravenous drug and xylazine use.
LEARNING OBJECTIVES:
Explain opioid use disorder as a chronic illness.
Increase level of comfort in the treatment and assessment of wound care as it relates to intravenous drug and Xylazine use.
Share best practices for incorporating harm reduction philosophies and principles in the treatment of opioid use disorder (OUD).
TRAINERS:
Nicole Gastala, MD
Dr. Gastala is board certified in Family Medicine and Addiction Medicine. She graduated from Loyola Stritch School of Medicine and completed her Family Medicine residency at the University of Iowa. In her clinical role, she has developed and expanded MAR by mentoring new prescribers, precepting residents, and training clinicians within the Chicago and Illinois communities. She has also focused on the development of a walk-in integrated behavioral health, addiction, and primary care program within her FQHC system. In January 2021, Dr Gastala joined the team at the Substance Use Prevention and Recovery Division of IDHS as the medical director.
Michael Huyck, NP
Michael Huyck is a Family Nurse Practitioner at the UIH Mile Square Health Center and adjunct clinical assistant professor with the University of Illinois College of Nursing. His clinical role at Mile Square is focused on integrative substance use disorder treatment and primary care. His clinical interests involve decreasing barriers to addiction care, piloting evidenced based interventions to address problems specific to populations with SUD, and training future nurses to care for those experiencing addiction. He provides a full range of SUD treatment including buprenorphine and methadone within his practice. His current projects include wound care and ultrasound guided phlebotomy for people who inject drugs.
The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
La falta de aceptación puede interferir con los atentos de ampliar el uso de tratamientos asistidos por medicamentos (TAM) para los trastornos por consumo de sustancias (TCS). Las Hojas Informativas de TAM ofrecen estrategias para generar apoyo para esta práctica basada en evidencia.
Hoja Informativa #1: Asegurando la Aceptación
Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación
Hoja Informativa #3: Abogando por las Medicamentos
Three-part webinar series offered by the Great Lakes ATTC and the Northwest ATTC.
Part 1 of the series provides an overview of stimulant (cocaine and methamphetamine) use in the U.S. Presenter Rick Rawson, PhD will discuss:
The extent and geography of stimulant use
Clinical syndromes produced by acute and chronic stimulant use
Strategies for addressing acute intoxication, withdrawal, and stimulant-induced psychosis
Effective behavioral treatments for stimulant use disorders
The status of pharmacotherapy research on treatments for stimulant use disorders
A discussion of vulnerable populations, including the problem of stimulant use by individuals in medication treatment for opioid use disorder
PowerPoint Presentation
Provides an overview of resources and initiatives to address opioid misuse in Illinois.
Information effective May 2019.
The risk of fatal overdose has changed significantly in recent years, most notably with the emergence of the illicit opioid fentanyl and the increasing prevalence of polypharmacy.
In this webinar, presenters Michael Hite, MBA and Desislav Hite, MD discussed trends and patterns in overdose cases over the last 5 years, factors that can increase overdose risk including identifiable life events and mental health co-occurring conditions, and how different populations are affected across Region 10. They also discussed actionable interventions to enhance overdose safety including new medical devices and digital resources, harm reduction strategies, and collaboration with local community organizations.
Download slides | View recording
Presenters: Sean Mahoney, Mental Health and Addiction Association of Oregon
December 2022
It's one thing to believe in harm reduction but how do we actually have those conversations with people actively using substances? And what other things should we know about besides Narcan and clean needles? Peer and recovery mentor Sean Mahoney has been having these conversations for years and is excited to share his experience navigating these difficult conversations with safety, compassion and love. Mahoney has also seen how this conversation has changed over the years due to fentanyl, COVID and the emerging mental health crisis. Harm reduction for opioids and heroin for sure but also for meth, alcohol, benzos and beyond will be covered in this course as will the techniques and approaches to have a trauma informed conversation to let the people we serve know that their lives matter.
Download slides | Watch recording
In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of the NIDA Clinical Trials Network, discussed recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants also learned about the treatment approaches to address this rising comorbidity.
This webinar was sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network.
Download slides
This one-hour, self-paced course on the HealtheKnowledge website is designed to equip peers and other outreach workers with information, resources, and practical tips to help them better understand opioids and their impact on individuals.
The course features four modules:
Role of Peers in Recovery
Opioids and the Brain
Treatment Options
Supporting Those Using Opioids
Learn about effective treatment options and strategies for using person-centered care to engage people with opioid use disorder in their path to recovery. 1 NAADAC/NBCC CEU available!
In partnership with Brown University SciToons and the Department of Emergency Medicine, the New England ATTC created the product "Opioid Overdose Rescue: 5 Ways to Save the Life." This educational video teaches the viewer how to recognize an overdose and how to effectively intervene. Watch the video to learn more.
The Naloxone is an Act of Love website was developed with support by the New England Addiction Technology Transfer Center (ATTC) in partnership with the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose. The website hosts a suite of resources designed to reduce stigma surrounding the use of naloxone and those who experience an opioid overdose along with encouraging viewers to get trained in and carry Naloxone. Specific resources include narrative videos, posters, and coasters.
Harm reduction is any action that reduces risk and increases personal and public safety. Harm reduction approaches have proven to prevent death, injury, disease, overdose, prevent substance misuse or disorder and most of us practice harm reduction techniques daily. For example, when we wear a seatbelt or apply sunscreen we are using harm reduction strategies. Fentanyl strips, naloxone, and needle exchange programs are also examples of harm reduction. This poster identifies some of the most common harm reduction methods in an attempt to normalize the term "harm reduction" and broaden the definition.
The Spanish translations were prepared by consultants for the Mountain Plains ATTC. While reasonable efforts are made to provide accurate translations, acknowledging the diversity of Spanish and English Language, some words/phrases may differ.
The poster can be downloaded in multiple formats directly from the MPATTC website. This product was designed for display as an 11x17 sized poster in a location most visible and accessible to behavioral health providers, educators, and/or peer recovery specialists but is also available in an 8.5x11 format for in-house printing. In addition, hard copies may be requested from the MPATTC by emailing us at
[email protected] (posters can be mailed within the continental United States). Please click on the link below for more information.
To request an 11x17 "What is Harm Reduction?" poster to be mailed directly to you, please click "REQUEST A HARD COPY".
This document is designed to reduce this information gap and help individuals and organizations better understand how the legal landscape in their state may impact access to harm reduction services and supplies, including overdose Good Samaritan laws, which provide limited protection from criminal sanctions to encourage people to call for help in an overdose emergency.
